We are live on ! Find out more
KYMR icon

Kymera Therapeutics
KYMR

97 hedge funds and large institutions have $887M invested in Kymera Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 6

29% more funds holding

Funds holding: 75 → 97 (+22)

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

5.29% more ownership

Funds ownership: 45.66% → 50.95% (+5.3%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

29% less capital invested

Capital invested by funds: $1.25B → $887M (-$360M)

Holders
97
Holders Change
+22
Holders Change %
+29.33%
% of All Funds
1.7%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
28
Increased
28
Reduced
25
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$66.8M
2
State Street
State Street
Massachusetts
+$46.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$32.6M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$23.9M
5
Morgan Stanley
Morgan Stanley
New York
+$20.1M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$61.5M
2
CCM
CAAS Capital Management
New York
-$10.5M
3
WP
Woodline Partners
California
-$10.5M
4
TOCUITCONY
Trustees of Columbia University in the City of New York
New York
-$9.04M
5
RG
Redmile Group
California
-$7.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$102M – – –
RG
2
Redmile Group
California
$101M -$7.06M -117,350 -4%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$91.4M -$5.4M -89,722 -4%
BBA
4
Baker Bros. Advisors
New York
$76.1M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$67.3M +$66.8M +1,109,285 +178%
DIC
6
Deer IX & Co
New York
$64.5M -$5.71M -94,885 -5%
BlackRock
7
BlackRock
New York
$58.8M +$5.86M +97,292 +7%
State Street
8
State Street
Massachusetts
$36.4M +$46.7M +776,370 +484%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$36.3M +$32.6M +540,902 +138%
Wellington Management Group
10
Wellington Management Group
Massachusetts
$26M -$61.5M -1,021,286 -60%
AIIC
11
AJU IB Investment Company
South Korea
$24.8M -$3.91M -65,000 -9%
RSCM
12
Rock Springs Capital Management
Maryland
$24.2M -$5.54M -92,088 -13%
BCLSI
13
Bain Capital Life Sciences Investors
Massachusetts
$18.6M – – –
Janus Henderson Group
14
Janus Henderson Group
United Kingdom
$15.5M +$23.9M +397,708 New
Morgan Stanley
15
Morgan Stanley
New York
$13.6M +$20.1M +333,257 +1,906%
TOCUITCONY
16
Trustees of Columbia University in the City of New York
New York
$12.2M -$9.04M -150,171 -32%
LGM
17
Logos Global Management
California
$10.1M +$9.03M +150,000 +135%
AG
18
Artal Group
Luxembourg
$9.71M – – –
SFM
19
Sphera Funds Management
Israel
$9.62M +$6.01M +99,827 +68%
Jennison Associates
20
Jennison Associates
New York
$7.25M +$7.06M +117,346 +169%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$7.25M -$317K -5,263 -3%
American Century Companies
22
American Century Companies
Missouri
$5.84M -$74.8K -1,243 -0.8%
Millennium Management
23
Millennium Management
New York
$4.96M +$7.69M +127,727 New
Citadel Advisors
24
Citadel Advisors
Florida
$4.85M +$7.51M +124,725 New
Northern Trust
25
Northern Trust
Illinois
$4.57M -$266K -4,425 -4%
1
2 3 4 5

KYMR Hedge Fund Activity: Q1 2021 in Review

97 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Kymera Therapeutics (KYMR) for Q1 2021, worth a combined $887M — down 29% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new KYMR positions and 6 closed out — a net gain of 22 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $66.8M. The largest seller was Wellington Management Group, cutting an estimated $61.5M.

  • 97 institutional investors held Kymera Therapeutics (KYMR) as of Q1 2021, up from 75 in Q4 2020.
  • Funds reported $887M of Kymera Therapeutics stock for Q1 2021, down 29% quarter-over-quarter.
  • 28 funds opened new Kymera Therapeutics positions in Q1 2021 and 6 closed out, a net change of +22 holders.
  • The largest Kymera Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $66.8M added.
  • The largest Kymera Therapeutics seller in Q1 2021 was Wellington Management Group, an estimated $61.5M sold.

Based on aggregated 13F filings for Q1 2021.